Neurocrine Biosciences (NBIX) Interest Coverage Ratio (2017 - 2024)

Neurocrine Biosciences has reported Interest Coverage Ratio for 8 years, with the latest figure at 90.27 in Q1 2024.

• For the quarter ending Q1 2024, Interest Coverage Ratio rose 186.95% year-over-year to 90.27; the trailing twelve-month figure through Dec 2024 stood at 518.64 (up 850.87% YoY), and the FY2023 full-year result was 54.54, up 55.53% from the prior year.
• Interest Coverage Ratio for Q1 2024 stood at 90.27, down from 136.64 in the prior quarter.
• The five-year high for Interest Coverage Ratio was 136.64 in Q4 2023, with the low at 103.82 in Q1 2023.
• Historically, Interest Coverage Ratio has averaged 31.65 across 5 years, with a median of 9.23 in 2020.
• Annual changes were most pronounced in 2022 — Interest Coverage Ratio jumped 1809.09% — and 2023, when it slumped 8807.33%.
• Neurocrine Biosciences' Interest Coverage Ratio stood at 9.21 in 2020, then tumbled by 159.75% to 5.5 in 2021, then jumped by 1809.09% to 94.0 in 2022, then soared by 45.36% to 136.64 in 2023, then sank by 33.93% to 90.27 in 2024.
• The last three Interest Coverage Ratio figures came in at 90.27 (Q1 2024), 136.64 (Q4 2023), and 128.36 (Q3 2023), per Business Quant data.